PGLEX | VTISX | PGLEX / VTISX | |
Total Expense Ratio | 0.80 | 0.05 | 1,702% |
Annual Report Gross Expense Ratio | 0.80 | 0.05 | 1,702% |
Fund Existence | 13 years | 9 years | - |
Gain YTD | 21.308 | 18.319 | 116% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 847M | 511B | 0% |
Annual Yield % from dividends | 3.18 | 2.85 | 112% |
Returns for 1 year | 20.59 | 15.03 | 137% |
Returns for 3 years | 46.10 | 34.09 | 135% |
Returns for 5 years | 15.31 | 38.03 | 40% |
Returns for 10 years | 52.39 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MTUL | 34.91 | N/A | N/A |
ETRACS 2x Lvrgd MSCI US Mntm Fctr TR ETN | |||
DMO | 11.81 | -0.01 | -0.13% |
Western Asset Mortgage Opportunity Fund | |||
RSJN | 33.34 | -0.08 | -0.23% |
FT Vest U.S. Eq Eq Wght Buffr ETF - Jun | |||
DFLV | 31.84 | -0.17 | -0.53% |
Dimensional US Large Cap Value ETF | |||
PPH | 88.45 | -1.22 | -1.36% |
VanEck Pharmaceutical ETF |